Pancreatic Cyst

• 

  Subject Areas on Research

  • A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas. 
  • A combination of molecular markers and clinical features improve the classification of pancreatic cysts. 
  • A multimodality test to guide the management of patients with a pancreatic cyst. 
  • A selective approach to resection of cystic lesions of the pancreas: results from 539 consecutive patients. 
  • A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. 
  • ACR Appropriateness Criteria® Pancreatic Cyst. 
  • Circulating Leptin and Branched Chain Amino Acids-Correlation with Intraductal Papillary Mucinous Neoplasm Dysplastic Grade. 
  • Clinical criteria for integrated molecular pathology in intraductal papillary mucinous neoplasm: less is more. 
  • Comparison of surgical and endoscopic sample collection for pancreatic cyst fluid biomarker identification. 
  • Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions. 
  • Current Controversy of Radiographic Surveillance of Patients With Branch-duct IPMN and Pancreatic Cysts: Commentary on: Ductal Carcinoma Arising in a Largely Unchanged Presumed Branch Duct IPMN After 10 Years of Surveillance. 
  • Current management of cystic neoplasms of the pancreas. 
  • Cyst Fluid Analysis in Pancreatic Intraductal Papillary Mucinous Neoplasms. 
  • Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period. 
  • Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients. 
  • Cystic pancreatic neuroendocrine tumors: a clinicopathologic study. 
  • Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry. 
  • Endoscopic ultrasound and computer tomography are inaccurate methods of classifying cystic pancreatic lesions. 
  • European evidence-based guidelines on pancreatic cystic neoplasms. 
  • Evaluation of cyst fluid CEA analysis in the diagnosis of mucinous cysts of the pancreas. 
  • GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs". 
  • How Long Should Patients with Cystic Lesions of the Pancreas Be Followed? 
  • Lymphoepithelial cyst of the pancreas. 
  • Mucinous cystic tumor of the pancreas: an analysis of FNA characteristics with an emphasis on the spectrum of malignancy associated features. 
  • Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas. 
  • Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet. 
  • Operative resection is currently overutilized for cystic lesions of the pancreas. 
  • Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia. 
  • Pancreatic cyst fluid glucose: rapid, inexpensive, and accurate diagnosis of mucinous pancreatic cysts. 
  • Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT. 
  • Pancreatic pseudocyst: comparative evaluation by sonography and computed tomography. 
  • Premalignant cystic neoplasms of the pancreas. 
  • Re: "Management of Incidental Pancreatic Cysts: A White Paper of the ACR Incidental Findings Committee". 
  • Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. 
  • Review of complications associated with endoscopic pancreatic cyst-gastrostomy: a single-institution experience. 
  • Serial EUS-Guided FNA for the Surveillance of Pancreatic Cysts: A Study of Long-Term Performance of Tumor Markers. 
  • Should Patients With Cystic Lesions of the Pancreas Undergo Long-term Radiographic Surveillance?: Results of 3024 Patients Evaluated at a Single Institution. 
  • Simple pancreatic cysts: CT and endosonographic appearances. 
  • Specific glycoforms of MUC5AC and endorepellin accurately distinguish mucinous from nonmucinous pancreatic cysts. 
  • TSPO-targeted PET and Optical Probes for the Detection and Localization of Premalignant and Malignant Pancreatic Lesions. 
  • The management of cystic lesions of the pancreas. 
  • The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis. 
  • Therapeutic Approach to Cystic Neoplasms of the Pancreas. 
  • Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. 
• 

  Keywords of People

  • Jowell, Paul Simon, Professor of Medicine, Medicine, Gastroenterology